CSIMarket



Amgen Inc.  (AMGN)
Other Ticker:  
 

Amgen's ROA per quarter

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


Return On Assets (Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Total Assets Change -0.8 % -5.35 % -2.83 % 0.55 % -8.06 %
Y / Y Net Income Change 183.84 % -10.33 % 17.59 % -6.78 % -74.27 %
Net Income (TTM) in Millions 6,576 5,723 5,893 5,609 5,746
Return On Assets (TTM) 10.75 % 9.34 % 9.49 % 8.97 % 9.2 %
Total Ranking # 712 # 859 # 906 # 843 # 770
Total Assets (TTM) in Millions 59,294 59,196 61,165 64,993 59,773
Seq. Total Assets Change 0.17 % -3.22 % -5.89 % 8.73 % -4.42 %
Seq. Net Income Change -10.77 % -22.27 % 0.8 % 306.03 % -71.81 %


Roa Comment
Amgen Inc. yielded Return on Asset in II. Quarter above company average, at 10.75 %.

Despite detoriation in net income, company improved return on assets compare to previous quarter.

Within Healthcare sector 92 other companies have achieved higher return on assets. While Return on assets total ranking has impoved so far to 712, from total ranking in previous quarter at 859.

What is ROA?
Return On Assets Company Ranking
Within: No.
Industry # 17
Sector # 93
Overall # 710

Return On Assets Statistics
High Average Low
12.98 %
9.74 %
2.49 %
(March 31, 2006)   (Dec 31 2017)


Financial Statements
Amgen's Assets $ 59,294 Millions AMGN's Balance sheet
Amgen's Income $ 1,317 Millions Quarterly AMGN's Income Statement
AMGN's Income by Division See AMGN's Income by Division



Annual Return On Assets (Dec 31 2021)
FY 2021
(Dec 31 2020)
FY 2020
(Dec 31 2019)
FY 2019
(Dec 31 2018)
FY 2018
(Dec 31 2017)
FY 2017
Y / Y Total Assets Change -2.83 % 5.43 % -10.1 % -16.93 % 3 %
Total Assets in Millions 61,165 62,948 59,707 66,416 79,954
Y / Y Net Income Change -18.87 % -7.37 % -6.58 % 324.15 % -74.37 %
Net Income in Millions 5,893 7,264 7,842 8,394 1,979
Return On Assets 9.63 % 11.54 % 13.13 % 12.64 % 2.48 %




Roa Comment
In the fiscal year 2021 Amgen's ROA decreased compare to previous year to 9.63 %, due to detoriation of net income -18.87 % to $5,893.00 millions, from $7,264.00 millions a year ago, as AMGN's assets were $61,165.00 millions.


More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Return On Asstes Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
AMGN's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Asstes
Lowest Ranking Return On Asstes
Roa for AMGN's Competitors
Roa for Amgen's Suppliers
Return On Asstes for AMGN's Customers

You may also want to know
AMGN's Roi AMGN's Inventory Turnover Ratio AMGN's Growth Rates AMGN's Dividend Comparisons
AMGN's Profitability Ratios AMGN's Asset Turnover Ratio AMGN's Dividend Growth
AMGN's Roe AMGN's Valuation Ratios AMGN's Financial Strength Ratios AMGN's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2022, within Healthcare Sector ROA
Prophase Labs Inc.  29.54 %
Fulgent Genetics Inc.  28.87 %
Harpoon Therapeutics Inc.  28.57 %
Maravai Lifesciences Holdings Inc.  28.03 %
Exelixis Inc.  27.94 %
Halozyme Therapeutics Inc.  27.35 %
Idexx Laboratories Inc  26.50 %
Mettler Toledo International Inc  24.82 %
Quidelortho Corp  24.47 %
Semler Scientific inc.  24.39 %
National Research Corporation  23.98 %
Oramed Pharmaceuticals Inc.  23.77 %
Lftd Partners Inc.  23.70 %
Dynavax Technologies Corporation  22.89 %
Vertex Pharmaceuticals Inc  22.86 %
Corcept Therapeutics Inc  22.84 %
Catalyst Pharmaceuticals Inc.  22.35 %
Regeneron Pharmaceuticals Inc.  22.16 %
Journey Medical Corporation  21.56 %
West Pharmaceutical Services Inc.  20.91 %
Innoviva Inc.  20.45 %
Chemed Corporation  19.91 %
Incyte Corp  19.38 %
Selecta Biosciences Inc  19.20 %
Avalo Therapeutics Inc.  19.16 %
Co diagnostics Inc.  18.75 %
Elite Pharmaceuticals Inc.  18.69 %
Edwards Lifesciences Corporation  17.37 %
Organogenesis Holdings Inc.  17.14 %
Zynex inc.  16.59 %



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

EDSFF's Profile

Stock Price

EDSFF's Financials

Business Description

Fundamentals

Charts & Quotes

EDSFF's News

Suppliers

EDSFF's Competitors

Customers & Markets

Economic Indicators

EDSFF's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071